Synthesis of 3'-O2-(azaheterocycle)-thymidines

Nucleosides, Nucleotides and Nucleic Acids

Volumn 19, Issue 4, 2000, Pages 735-748

  Prestat, Guillaume ^a   Dubreuil, Didier ^a   Adjou, Ané ^b   Pradère, Jean Paul ^a   Lebreton, Jacques ^a   Evers, Michel ^c   Henin, Yvette ^c  

^a CNRS   (France)

^b Fac des Sci et Techniques   (Côte d’Ivoire)

^c SANOFI   (France)

Author keywords

1 thia 3 azabutadienes; 3' modified thymidine; 4H 1,3 thiazines; Thiazol 2 ine; Thiazoles; Thioacylamidines; Thioacylimines

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; THYMIDINE DERIVATIVE; DRUG DERIVATIVE; HETEROCYCLIC COMPOUND; RNA DIRECTED DNA POLYMERASE; THYMIDINE;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG DNA BINDING; DRUG SYNTHESIS; FRANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; CELL CULTURE; CYTOTOXICITY TEST; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

HUMAN IMMUNODEFICIENCY VIRUS; THIA;

ANTI-HIV AGENTS; AZA COMPOUNDS; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; HIV-1; LYMPHOCYTES; MAGNETIC RESONANCE SPECTROSCOPY; RNA-DIRECTED DNA POLYMERASE; THYMIDINE;

EID: 0033624297     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1080/15257770008035021     Document Type: Article

References (55)

1. Reviews; a) Perigaud, C.; Gosselin, G.; Imbach. J.-L. Nucleosides & Nucleotides 1992, 11, 903.
2. b) Huryn, D.M.; Okabe, M. Chem. Rev. 1992, 92, 1745.
3. a) Ono K.; Ogaswara, M.; Iwata, Y.; Nakane, H.; Fuji, T.; Sawai, K.; Saneyoshi, M. Biochem. Biophys. Res. Commun. 1986, 140, 498.
4. b) Mitsuya, H.; Broder, S. Nature 1987, 325, 773.
5. c) Balzarini, J.; Masaroni, B.; Pauwel, R.; Herdewijn, P.; Wood, S.G.; Robins, M.J.; De Clercq, E. Mol. Pharmacol. 1988, 33, 243.
6. d) Wigerinck, P.; Van Aerschot, A.; Claes, P.; Balzarini, J.; De Clercq, E.; Herdewijn, P. J. Heterocyclic Chem. 1989, 26, 1635 and references therein.
7. e) Yarchoan, R.; Mitsuya, H.; Thomas, R.V.; Pluda, J.M.; Hartman, N.R.; Perno, C.-F.; Marczyk, K.S.; Allain, J.-P.; Johns, D.G.; Broder, S. Science 1989, 245, 412.
8. f) Matsuda, A.; Satoh, M.; Ueda, T.; Machida, H.; Sasaki, T. Nucleosides & Nucleotides 1990, 9, 587 and references therein.
9. g) Secrist, J.A.; Riggs, R.M.; Tiwari K.N.; Montgomery, J.A. J. Med. Chem. 1992, 35, 533.
10. a) Hao, Z.; Cooney, D.A.; Hartman, N.R.; Perno, C.F.; Fridland, A.; De Vico, A.L.; Sarngadharan, M.G.; Broder, S.; Johns, D.G. Mol. Pharmacol. 1988, 34, 431.
11. b) Larder, B.A.; Darby, G. Richman D.D. Science 1989, 243, 1731.
12. c) Schreiber, S.L.; Ikemoto, N. Tetrahedron Lett. 1988, 29, 3211.
13. d) Maillard, M.; Faraj, A.; Frappier, F.; Florent, J.C.; Grierson, D.S.; Monneret, C. Tetrahedron Lett. 1989, 30, 1955.
14. a) Seela, F.; Becher, G.; Rosemeyer, H.; Reuter, H.; Kastner, G.; Mikhailopulo, I.A. Helv. Chim. Acta 1999, 82, 105.
15. b) Ramzaeva, N.; Mittelbach, C.; Seela, F. Helv. Chim. Acta 1999, 82, 12. and references therein
16. c) Wigerinck, P.; Van Aerschot, A.; Janssen, G.; Claes, P.; Balzarini, J.; De Clercq, E.; Herdewijn, P. J. Med. Chem. 1990, 33, 868.
17. d) Nair, V.; Nuesca, Z.M. J. Am. Chem. Soc. 1992, 114, 7951.
18. e) Sujino, K.; Sugimura, H. J. Chem. Soc., Chem. Commun. 1994, 11, 2541 and references therein.
19. f) Kakefuda, A.; Shuto, S.; Nagahata, T.; Seki, J.-I.; Sasaki, T.; Matsuda, A. Tetrahedron 1994, 50, 10167.
20. g) Costa, A. M.; Faja, M.; Farràs, J.; Vilarrasa, J. Tetrahedron Lett. 1998, 39, 1835 and references therein.
21. h) Kasnar, B.; Skaric, V.; Klaic, B.; Zinic, M. Tetrahedron Lett. 1993, 34, 4997 and references therein.
22. i) Mikhailov, S.; De Clercq, E.; Herdewijn, P. Nucleosides & Nucleotides 1996, 75, 1323.
23. j) Derry, W.B.; Pamidi, C.C.; Gupta, R.S. Anticancer Drug. Design 1993, 8, 203.
24. a) Camarasa, M.J.; Pérez-Pérez, M.J.; Velazquez, S.; San-Félix, A.; Alvarez, R.; Ingate, S.; Jimeno, M.L.; De Clercq, E.; Balzarini, J. Spec. Publ. - R. Soc. Chem. 1997, 198, 259.
25. b) Pérez-Pérez, M.J.; San-Félix, A.; Camarasa, M.J.; Balzarini, J.; De Clercq, E. Tetrahedron Lett. 1992, 33, 3029.
26. c) Ingate, S.; Camarasa, M.J.; De Clercq, E.; Balzarini, J. Antiviral Chem. Chemother. 1995, 6, 365.
27. d) San-Félix, A.; Alvarez, R.; Velàzquez, S.; De Clercq, E.; Balzarini, J.; Camarasa, M. J. Nucleosides & Nucleotides 1995, 14, 595.
28. a) Alvarez, R.; Jimeno, M.-L.; Gago, F.; Balzarini, J.; Pérez-Pérez, M.J.; Camarasa, M.J. Antiviral Chem. Chemother. 1998, 9, 333.
29. b) Garg, R.; Gupta, S.P. J. Enzyme Inhib. 1997, 11, 171.
30. c) Alvarez, R.; Velazquez, S.; San-Félix, A.; Aquaro, S.; De Clercq, E.; Perno, C.F.; Karlsson, A.; Balzarini, J.; Camarasa, M.J. J. Med. Chem. 1994, 37, 4185.
31. d) Balzarini, J.; Karlsson, A.; Vandamme, A.M.; Pérez-Pérez, M.J.; Zhang, H.; Vrang, L.; Öberg, B.; Bäckbro, K.; Unge, T.; San-Félix, A.; Velàzquez, S.; Camarasa, M.J.; De Clercq, E. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6952.
32. a) Boger, D.L.; Weinreb, S.M. "Hetero Diets-Alder Methodology in Organic Synthesis", 1987, Academic Press, San Diego and references therein.
33. b) Meslin, J.C.; Quiniou, H. Tetrahedron 1975, 31, 3055.
34. c) Meslin, J.C.; Quiniou, H. Bull. Soc. Chim. Fr., 1979, 7-8, 347.
35. d) Tea, C.G.; Pradère, J.P.; Quiniou, H.; Toupet, L. J. Chem. Soc., Perkin Trans. 1985, pp. 1875.
36. e) Pradère, J.P.; Roze, J.C.; Quiniou, H.; Danion-Bougot, R.; Danion, D.; Toupet, L. Can. J. Chem., 1986, 64, 597.
37. f) Weinreb, S.M.; Scola, P.M. Chem. Rev. 1989, 89, 1525 and references therein.
38. g) Chehna, M.; Pradère, J.P.; Quiniou, H.; Le Botlan, D.; Toupet, L. Phosphorus, Sulfur and Silicon 1989, 42, 15.
39. h) Pradère, J.P.; Tonnard, F.; Abouelfida, A.; Cellerin, C.; Andriamanamihaja, M.; Jousseaume, B.; Toupet, L.; Guenot, P. Bull. Soc. Chim. Fr. 1993, 130, 610.
40. i) Guemas, J.P.; Lees, M.; Reliquet, A.; Villieras, J. Phosphorus and sulfur 1982, 12, 325.
41. j) Toure, S.A.; Voglozin, A.; Degny, E.; Danion-Bougot, R.; Danion, D.; Pradère, J.P.; Toupet, L.; N'Guessan, Y.T. Bull. Soc. Chim. Fr. 1991, 128, 574.
42. k) Tea, C.G.; Chehna, M.; Pradère, J.P.; Duguay, G.; Toupet, L. Phosphorus and Sulfur 1986, 27, 327.
43. l) Reliquet, A.; Meslin, J.C.; Reliquet, F.; Benhadda, D.; Brossard, B. Sulfur Lett. 1987, 7, 49 and references therein.
44. m) Hérail, M.; Purseigle, F.; Goli, M.; Dubreuil, D.; Pradère, J.P.; Proutière, A. J. Mol. Struct. 1996, 382, 39.
45. Prestat, G.; Adjou, A; Dubreuil, D.; Pradère, J. P results to be submitted.
46. a) Hanessian, S.; Lavallée, P. Can. J. Chem. 1975, 53, 2975.
47. b) Clivio, P.; Fourrey, J.L.; Szabo, T.; Stawinski, J. J. Org. Chem. 1994, 59, 7273.
48. Dyatkina, N.B.; Azhayev, A.V. Synthesis 1984, p. 961.
49. Corey, E.J.; Chaykovsky, M. J. Am. Chem. Soc. 1965, 87, 1353.
50. Abouelfida, A.; Pradère, J.P.; Jubault, M.; Tallec, A. Can. J. Chem. 1992, 70, 14.
51. Leydet, A.; Barthelemy, Ph.; Boyer, B.; Lamaty G. and Roque J. P.; Bousseau, A.; Evers, M. and Henin, Y.; Snoecck, R.; Andei, G.; Ikeba, S.; Reymen, D. and De Clercq, E. J. Med Chem. 1995, 38, 2433.
52. a) Welch, M. B. and Burgess, K. Nucleosides & Nucleotides 1999, 18, 197.
53. b) Metzker, M. L.; Raghavachari, R.; Richards, S. Jacutin, S. E.; Ciitello, A.; Burgess, K.; Gibbs, R. A. Nucl. Acids. Res. 1994, 22, 4259.
54. rd ed; Butterworths-heinemann Ltd.; Oxford, 1988.
55. Dr P. Guenot, Centre Régional de Mesures Physiques de l'Ouest, Université de Rennes I, Campus de Beaulieu, 35042 Rennes Cedex.